Premature Luteinization Prevention by GnRH Antagonist in Patients Undergoing IUI
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
Premature luteinization in patients undergoing IUI can occur in up to 24% of cycles. These
patients, according to recent data, have a lower pregnancy rate than controls. The
possibility to avoid premature luteinization with GnRH antagonist may restore the chances of
achieving a pregnancy in these women.